Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content

Women in STEM: Inspiration from Innovators in Pharma

BySusan Haigney

February 2nd 2026

Cellares Secures $257M | Created with Canva

Cellares Secures $257M to Scale Global Cell Therapy Manufacturing

ByChristopher Cole

January 29th 2026

Nerve cell with blue background attacked by red antibodies - 3D illustration of autoimmune disease | Image Source: ©peterschreiber.media -stock.adobe.com

Repertoire Immune Medicines and Lilly Collaborate on Treatments for Autoimmune Diseases

BySusan Haigney

January 29th 2026

Leveraging Next-Gen Therapies, Advanced Purification, and Strategic Collaborations in Pharma Production

BySusan Haigney,Zachary Zubulake

January 26th 2026

Integrating AI Discovery, Continuous Manufacturing, and Modern Regulatory Hurdles into Pharma Production

BySusan Haigney

January 23rd 2026

Outsourcing Outlook

Articles in this issue

Newsletter

Related Content

Women in STEM: Inspiration from Innovators in Pharma

Cellares Secures $257M to Scale Global Cell Therapy Manufacturing

Repertoire Immune Medicines and Lilly Collaborate on Treatments for Autoimmune Diseases

Leveraging Next-Gen Therapies, Advanced Purification, and Strategic Collaborations in Pharma Production

Integrating AI Discovery, Continuous Manufacturing, and Modern Regulatory Hurdles into Pharma Production

Trending on Pharmaceutical Technology

FDA Launches PreCheck Pilot Program to Bolster Domestic Drug Manufacturing

FDA Grants Priority Review to AZ's Datroway for Metastatic Triple Negative Breast Cancer

Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D

Cellares Scales IDMO Model for Gene-Edited Stem Cells Therapies

Behind the Headlines Episode 32: AI’s Power, NVIDIA & Lilly, Revolution Medicine